terameprocol has been researched along with Cancer of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giacalone, NJ; Lu, B; Sun, Y | 1 |
Dorr, RT; Lambert, JD; Meyers, RO; Timmermann, BN | 1 |
2 other study(ies) available for terameprocol and Cancer of Lung
Article | Year |
---|---|
Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma.
Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Masoprocol; Radiation-Sensitizing Agents; Sp1 Transcription Factor; Survivin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2011 |
tetra-O-methylnordihydroguaiaretic acid inhibits melanoma in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Colonic Neoplasms; DNA Replication; Female; Intracellular Membranes; Kidney; Liver; Lung Neoplasms; Male; Masoprocol; Melanoma; Melanoma, Experimental; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Neoplasm Transplantation; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |